Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)

Medical Decision Making

Volumn 22, Issue 4, 2002, Pages 340-349

  Clarke, Philip ^a   Gray, Alastair ^a   Holman, Rury ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Diabetes; Diabetes related complications; EQ 5D; Quality of life; Utility; Visual analog scale

Indexed keywords

ARTICLE; BLINDNESS; HEALTH STATUS; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIMB AMPUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY OF LIFE; QUESTIONNAIRE; STROKE;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 2; FEMALE; GREAT BRITAIN; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; SICKNESS IMPACT PROFILE;

EID: 0036071652     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/027298902400448902     Document Type: Article

References (34)

1. The measurement of health-related quality of life
2. The Beaver Dam Health Outcomes Study: Initial catalog of health-state quality factors
3. Quality-of-life outcomes in men treated for localized prostate cancer
4. UK Prospective Diabetes Study VIII: Study design, progress and performance
5. Health econometrics
6. Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial
7. A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus: Impact on glycemic control and health-related quality of life
8. Quality of life and associated characteristics in a large national sample of adults with diabetes
9. Health related quality of life in diabetic patients measured by the Nottingham Health Profile
10. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial
11. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37)
12. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
13. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
14. EuroQol - A new facility for the measurement of health-related quality of life
15. The time trade-off method: Results from a general population study
16. Health state valuations from the general public using the visual analogue scale
17. Modeling valuations for EuroQol health states
18. Least absolute deviations estimation for the censored regression model
19. Semiparametric censored regression models
20. Intraclass correlations: Uses in assessing rater reliability
21. Much ado about two: Reconsidering retransformation and the two-part model in health econometrics
22. Evaluation of index and profile measures of health status in a randomized controlled trial: Comparison of the Medical Outcomes Study 36-Item Short Form Health Survey, EuroQol, and disease specific measures
23. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40
24. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: Economic analysis alongside a randomised controlled trial: UKPDS 41
25. Skills, schooling, and household income in Ghana
26. A statistical model for the analysis of ordinal level dependent variables
27. Goodness of fit measures in the tobit model
28. Marginal effects in the censored regression model
29. The uses of tobit analysis